Figure 1From: Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapyRepresentative examples of immunohistochemistry staining intensity for p-AKT (low intensity, panel A; high intensity, panel B) and p-ERK (low intensity, panel C; high intensity, panel D) at 60× magnification.Back to article page